Targeting conserved viral virulence determinants by single domain antibodies to block SARS-CoV2 infectivity
S. Singh, S. Dahiya, Y. J. Singh…·S. Sehrawat
This study identifies single domain antibodies that neutralize SARS-CoV2 by targeting the cleavage site and receptor binding domain of the spike protein, showing their stability and effectiveness in blocking infectivity.